Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
---|
12/28/1995 | WO1995035094A1 Sphingosomes for enhanced drug delivery |
12/28/1995 | WO1995035093A1 In situ gel-forming delivery vehicle for bio-affecting substances, and method of use |
12/28/1995 | WO1995035073A1 Ophthalmic delivery system |
12/28/1995 | WO1995024929A3 Polymeric gene delivery system |
12/28/1995 | CA2193806A1 Controlled release device and method |
12/28/1995 | CA2193396A1 A pharmaceutical composition for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for the treatment thereof |
12/28/1995 | CA2193362A1 Modulators of pneumococcal adhesion to cellular targets involving the platelet activating factor receptor, and uses thereof |
12/28/1995 | CA2193359A1 Compositions for applying active substances to or through the skin |
12/28/1995 | CA2193100A1 Transdermal therapeutic system with active substances constituting sources of carbon monoxide |
12/28/1995 | CA2192961A1 The improved long acting gi and esophageal protectant |
12/28/1995 | CA2192712A1 Nanoparticles stabilized and filterable in sterile conditions |
12/28/1995 | CA2192708A1 In situ gel-forming delivery vehicle for bio-affecting substances, and method of use |
12/28/1995 | CA2151335A1 Non-reducing saccharide and its production and use |
12/28/1995 | CA2150888A1 Powder preparation for healing damaged skin |
12/27/1995 | EP0689052A2 Insulin standard solution |
12/27/1995 | EP0688761A2 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
12/27/1995 | EP0688565A1 Tablet, capsule, or granule comprising desogestrel |
12/27/1995 | EP0688564A2 Method of controlling release of an active or drug from a silicone rubber matrix |
12/27/1995 | EP0688563A1 Process for producing liposome composition |
12/27/1995 | EP0688429A1 Macromolecular microparticles and methods of production |
12/27/1995 | EP0688337A1 Compositions and methods for the treatment of immunomediated inflammatory disorders |
12/27/1995 | EP0688329A1 Novel phospholipid-saccharide conjugates |
12/27/1995 | EP0688229A1 Use of low density lipoprotein with cytotoxic substances |
12/27/1995 | EP0688211A1 Methods and compositions for inhibition of angiogenesis |
12/27/1995 | EP0688209A1 Glycosylation of lipids and lipid-containing particles, and diagnostic and therapeutic methods and materials derived therefrom |
12/27/1995 | EP0688208A1 Sugar- and sodium-free effervescent tablets and granules and process for preparing same |
12/27/1995 | EP0688207A1 Lipid-polymer conjugates and liposomes |
12/27/1995 | EP0688206A1 Vaccine delivery system and shelf-stable precursor solution for remote encapsulation of active ingredients |
12/27/1995 | EP0688205A1 Polymeric mucoadhesives in the delivery of immunogens at mucosal surfaces |
12/27/1995 | EP0688166A1 Proteinaceous oil spill dispersant |
12/27/1995 | EP0646002B1 Preparation and use of novel cyclodextrin-based dispersible nanovesicular colloidal systems in the form of nanocapsules |
12/27/1995 | EP0623018B1 Process for the manufacture of soft gelatin capsules by a drip-feed method |
12/27/1995 | EP0555333B1 Artificial viral envelopes |
12/27/1995 | EP0553351B1 CRYSTALLINE MODIFICATION OF HYDROCHLORIDE OF 2-DIMETHYLAMINOETHYL ETHER OF n-BUTYLAMINO BENZOIC ACID, METHOD OF OBTAINING IT AND PHARMACEUTICAL PREPARATION FOR ANESTHESIA OF THE EYE BASED THEREUPON |
12/27/1995 | EP0542864B1 Use of phospholipids for the manufacture of a topical medicament for modifying serum cholesterol levels |
12/27/1995 | CN1113806A Chuangsuyu (a vulnerary for promoting healing of wound) and its preparation method |
12/27/1995 | CN1113785A Acanthopanax root injection freeze-dried powder injection and producing technology for acanthopanax root extract |
12/27/1995 | CN1113775A Recipe of injection for curing sciatica and producing technology |
12/26/1995 | US5478925 Peptides which block the binding of Tumor Necrosis Factor to its receptors |
12/26/1995 | US5478860 Stable microemulsions for hydrophobic compound delivery |
12/26/1995 | US5478847 Methods of use for inhibiting bone loss and lowering serum cholesterol |
12/26/1995 | US5478829 Solution of sparfloxacin, its preparation and salt of which it is composed |
12/26/1995 | US5478819 Treating helico bacter infection with synergistic mixture of antibiotic and phsophatide |
12/26/1995 | US5478816 Liquid vitamin formulations containing vitamin D esters |
12/26/1995 | US5478814 Hemorrhoidal, other compositions and methods of treatment |
12/26/1995 | US5478593 Applying a polyol syrup such as sorbitol or maltitol followed by application in powder form; carried out without forced drying; chewing gums |
12/26/1995 | US5478578 Micronized active material, excipient mixture with fine and coarse particles |
12/26/1995 | US5478577 Administering controlled release dosage form of opiate analgesics |
12/26/1995 | US5478575 Polymers having benzeneboronic acid groups and insulin complexes of same of a sugar response type |
12/26/1995 | US5478574 Agglomerated hydrophilic complexes with multi-phasic release characteristics |
12/26/1995 | US5478573 Delayed, sustained-release propranolol pharmaceutical preparation |
12/26/1995 | US5478572 Cellulosic polymer matrix and excipients; extended release; side effect reduction; antidepressants and anxiolytic agents |
12/26/1995 | US5478571 Process for the preparation of substantially alcohol free pharmaceutical compositions |
12/26/1995 | US5478570 Process for producing capsule and capsule obtained thereby |
12/26/1995 | US5478569 Cold water dispersible particles of fat-soluble substance encapsulated with protective fish gelatin colloid; nutritional supplements |
12/26/1995 | US5478568 Controlled release of active component into blood; inhibits vomiting occuring as side effect of chemotherapy drugs for cancer treatment; no skin rash |
12/26/1995 | US5478567 Drug, such as ketoprofen, rosin solubiizer, polymer, softener polyester cloth backing |
12/26/1995 | US5478565 Treatment of sinus headache |
12/26/1995 | US5478564 Emulsifying a polypeptide and a polylactone in an immiscible organic solvent aqueous solution, desolventizing by evaporation |
12/26/1995 | US5478561 Process for the preparation of stable complex multiple emulsions of the water-oil water systems |
12/26/1995 | US5478501 Bathing composition containing coated cationic polymer |
12/26/1995 | US5477857 Measuring myocardial function in mammals |
12/26/1995 | CA2021534C Antiallergic spray preparations |
12/26/1995 | CA1337801C Immobilized artificial membranes |
12/26/1995 | CA1337797C Medicated cleansing pads |
12/21/1995 | WO1995034588A1 Cross-linked polymers for removing bile salts from a patient |
12/21/1995 | WO1995034582A1 Bioadhesive starches and process for their preparation |
12/21/1995 | WO1995034528A1 Polyolpolyhydroxystearates |
12/21/1995 | WO1995034328A1 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
12/21/1995 | WO1995034294A1 Controlled release oral drug delivery system |
12/21/1995 | WO1995034293A1 Process and apparatus for making rapidly dissolving dosage units and product therefrom |
12/21/1995 | WO1995034292A2 Stabilized biologically active compounds contained in coated microgranules which can be suspended in alimentary fluids |
12/21/1995 | WO1995034291A1 Pellets |
12/21/1995 | WO1995034290A1 Quickly dispersing comestible unit and product |
12/21/1995 | WO1995034289A1 Compositions for neutralization of lipopolysaccharides |
12/21/1995 | WO1995034288A1 Methods of treating hypertension and of improving impaired renal function |
12/21/1995 | WO1995034287A1 Lipid based composition containing diacylglycerol, phospholipid, polar liquid and biologically active material |
12/21/1995 | WO1995034286A1 Transmucosal delivery system |
12/21/1995 | WO1995034285A1 Dosage form for administering drug in liquid formulation |
12/21/1995 | WO1995034284A1 Pharmaceutical preparation with a hydrophobic active substance and an effervescent system, and process for preparing said preparation |
12/21/1995 | WO1995034283A1 Effervescent system with an alkali- and/or metal-sensitive pharmaceutical active substance and process for producing the same |
12/21/1995 | WO1995034279A1 NON-IRRITANT AQUEOUS LIPOSOME DISPERSIONS CONTAINING α-HYDROXYCARBOXYLIC ACIDS, α-KETOCARBOXYLIC ACIDS AND/OR SALICYCLIC ACID IN THEIR SALT FORMS |
12/21/1995 | WO1995034262A1 Transdermal treatment of malaria |
12/21/1995 | WO1995030423A3 Cancer treatment and metastasis prevention |
12/21/1995 | WO1995024430A3 Block and graft copolymers and methods relating thereto |
12/21/1995 | WO1995022965A3 Nasal and ocular administration of ketamine to manage pain and for detoxification |
12/21/1995 | WO1995020660A3 Immunization by inoculation of dna transcription unit |
12/21/1995 | DE4420708A1 Pharmaceutical compsn. for inhalation |
12/21/1995 | CA2192661A1 Compositions for neutralization of lipopolysaccharides |
12/21/1995 | CA2192587A1 Process and apparatus for making rapidly dissolving dosage units and product therefrom |
12/21/1995 | CA2192541A1 A bio-erodible matrix for the controlled release of medicinals and the assay of hydrolytic enzymes |
12/21/1995 | CA2192355A1 Quickly dispersing comestible unit and product |
12/21/1995 | CA2186597A1 Non-irritant aqueous liposome dispersions containing .alpha.-hydroxycarboxylic acids, .alpha.-ketocarboxylic acids and/or salicyclic acid in their salt forms |
12/21/1995 | CA2152005A1 L-carnitine salt and compositions containing same |
12/21/1995 | CA2150407A1 L-carnitine salt and cosmetic and pharmaceutical compositions containing same for treating dermatoses |
12/20/1995 | EP0687498A2 Dispersed systems and method of manufacture |
12/20/1995 | EP0687473A1 Optical isomerization inhibitor |
12/20/1995 | EP0687466A1 Homeopathic formulations |
12/20/1995 | EP0687464A2 Process for manufacturing effervescent tablets and effervescent tablets |
12/20/1995 | EP0687463A1 Hemoglobin-encapsulated liposome |